Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2007-11-12
pubmed:abstractText
Prion protein (PrPc) has been previously reported to be associated with resistance to proapoptotic stimuli. We evaluated whether the expression of PrPc was associated with the resistance to adjuvant chemotherapy in patients with estrogen receptor (ER) -negative breast cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1569-8041
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1793-8
pubmed:meshHeading
pubmed-meshheading:17872899-Adult, pubmed-meshheading:17872899-Aged, pubmed-meshheading:17872899-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17872899-Breast Neoplasms, pubmed-meshheading:17872899-Chemotherapy, Adjuvant, pubmed-meshheading:17872899-Disease-Free Survival, pubmed-meshheading:17872899-Female, pubmed-meshheading:17872899-Gene Expression Regulation, Neoplastic, pubmed-meshheading:17872899-Humans, pubmed-meshheading:17872899-Mastectomy, pubmed-meshheading:17872899-Middle Aged, pubmed-meshheading:17872899-PrPC Proteins, pubmed-meshheading:17872899-Probability, pubmed-meshheading:17872899-Prognosis, pubmed-meshheading:17872899-Proportional Hazards Models, pubmed-meshheading:17872899-Randomized Controlled Trials as Topic, pubmed-meshheading:17872899-Receptors, Estrogen, pubmed-meshheading:17872899-Risk Assessment, pubmed-meshheading:17872899-Statistics, Nonparametric, pubmed-meshheading:17872899-Survival Analysis, pubmed-meshheading:17872899-Treatment Outcome, pubmed-meshheading:17872899-Tumor Markers, Biological
pubmed:year
2007
pubmed:articleTitle
Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer.
pubmed:affiliation
Institut National de la Santé et de la Recherche Médicale, Laboratoire d'Immunologie des Tumeurs Humaines: Interaction effecteurs cytotoxiques-système tumoral, Institut Gustave Roussy PR1 and IFR 54, 94805 Villejuif Cedex. France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't